No single food or supplement reliably shuts down glutamine metabolism in the human body the way a pharmaceutical drug can, but a growing body of preclinical research has identified several naturally occurring compounds that interfere with glutamine uptake, conversion, or signaling in cell and animal studies. These include polyphenols from green tea and grapes, alkaloids from plants like goldenseal, and isothiocyanates from cruciferous vegetables. The catch is that nearly all of this evidence comes from lab dishes and rodent models, not clinical trials in people, so the leap from “this compound blocked glutamine use in cancer cells” to “eating this food will meaningfully block glutamine in your body” remains large and unproven.
Why Glutamine Metabolism Matters
Glutamine is the most abundant amino acid circulating in your blood, and your body uses it for everything from fueling immune cells to maintaining the gut lining. The interest in blocking it comes primarily from cancer research. Many tumors rewire their internal chemistry to consume glutamine at abnormally high rates, a process called glutaminolysis. The enzyme glutaminase (particularly the GLS1 form) converts glutamine into glutamate, feeding it into energy-production pathways that support rapid cell division.1PubMed Central. Glutaminase – A potential target for cancer treatment When researchers knock out or inhibit GLS1 in colorectal cancer cells, for example, cell proliferation drops and internal energy levels fall.2PubMed Central. Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer
Glutamine also feeds into the production of glutathione, the cell’s main antioxidant defense molecule. Cancer cells exploit this to protect themselves against oxidative stress and certain types of cell death. Disrupting that pipeline, even partially, can make cancer cells more vulnerable. Research on GLS1 knockout cells showed that their proliferation could be rescued by adding back glutamate or amino acids that convert into glutamate, confirming that glutamine’s role as a glutamate source is central to why cancer cells crave it.3PubMed Central. Glutaminase-1 Mediated Glutaminolysis to Glutathione Synthesis Maintains Redox Homeostasis and Modulates Ferroptosis Sensitivity in Cancer Cells
The practical question is whether any of this can be achieved through diet or natural compounds. The honest answer: partially, in a lab setting. What follows is a compound-by-compound look at what the research actually shows.
EGCG From Green Tea
The most extensively studied natural glutamine-metabolism inhibitor is epigallocatechin gallate, or EGCG, the main polyphenol in green tea. EGCG does not block glutaminase directly. Instead, it inhibits glutamate dehydrogenase (GDH), the enzyme that processes glutamate downstream of glutaminase. Early biochemical work found that EGCG and a related green tea compound, epicatechin gallate, inhibited GDH at very low concentrations, performing comparably to the body’s own natural GDH inhibitor.4Journal of Biological Chemistry. Green Tea Polyphenols Modulate Insulin Secretion by Inhibiting Glutamate Dehydrogenase
In transgenic mice engineered to have overactive GDH, oral EGCG administration before an amino acid challenge blocked the abnormal insulin response that the mice would otherwise exhibit, confirming that the compound works in a living system, not just a test tube.5PubMed Central. Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the ADP activation site A review of glutamine-targeting strategies in cancer also noted that EGCG suppresses the growth of neuroblastoma, glioma, and colorectal cancer cells through its GDH-inhibiting activity.6Experimental & Molecular Medicine. Targeting glutamine metabolism as a therapeutic strategy for cancer
The limitation is dose. The concentrations used in cell studies are hard to achieve by drinking green tea. Supplements delivering higher EGCG doses exist, but high-dose EGCG has been linked to liver toxicity in some cases, so “more is better” is not a safe assumption. Still, among natural compounds, EGCG has the strongest mechanistic evidence for directly interfering with a key step in glutamine processing.
Resveratrol and Sulforaphane
Resveratrol, the polyphenol found in red grape skins, red wine, and berries, affects glutamine metabolism through a different door. In human liver cancer cells, resveratrol reduced the expression of ASCT2, one of the main transporter proteins that shuttles glutamine into cells. With fewer transporters on the cell surface, both glutamine absorption and downstream glutathione content dropped, making the cancer cells more sensitive to the chemotherapy drug cisplatin.7PubMed Central. Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition Separately, prostate cancer cells treated with resveratrol showed a measurable decrease in glutamine metabolism when tracked using advanced imaging techniques.8PubMed. Probing treatment response of glutaminolytic prostate cancer cells to natural drugs with hyperpolarized [5-(13) C]glutamine
Sulforaphane, the compound released when you chew or chop broccoli, cauliflower, and especially broccoli sprouts, takes yet another approach. Rather than simply blocking glutamine use, sulforaphane appears to redirect how cells handle glutamate once it is made from glutamine. It diverts glutamate away from energy-production cycles and toward glutathione synthesis, essentially reprogramming the metabolic flow.9PubMed Central. Sulforaphane rewires central metabolism to support antioxidant response and achieve glucose homeostasis That same prostate cancer imaging study found that sulforaphane, like resveratrol, significantly decreased glutamine metabolism in cancer cells.8PubMed. Probing treatment response of glutaminolytic prostate cancer cells to natural drugs with hyperpolarized [5-(13) C]glutamine
In a small human pilot study, daily oral sulforaphane for seven days increased blood glutathione levels and showed a correlated rise in brain glutathione as well.10PubMed Central. Sulforaphane Augments Glutathione and Influences Brain Metabolites in Human Subjects: A Clinical Pilot Study That is interesting because it suggests sulforaphane genuinely alters glutamine-related metabolism in living people, though the study was tiny and not focused on cancer outcomes. Whether boosting glutathione in healthy tissue while disrupting it in tumors is achievable through diet alone remains unclear.
Berberine and Quercetin
Berberine, the bright yellow alkaloid found in goldenseal, Oregon grape root, and barberry, suppresses glutamine uptake in liver cancer cells by a chain of events starting with the oncogene c-Myc. Cancer cells often rely on c-Myc to ramp up production of the glutamine transporter SLC1A5 (which is closely related to ASCT2). Berberine dials down c-Myc expression in a dose-dependent fashion, and the transporter levels drop along with it. When researchers artificially forced c-Myc back up, berberine’s inhibitory effect on both the transporter and cell growth was reversed, confirming the link.11PubMed Central. Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake
Quercetin, a flavonoid abundant in onions, apples, capers, and many leafy greens, has a different and more unusual target. A derivative of quercetin isolated from a wild Saharan plant was found to inhibit glutamine synthetase, the enzyme that builds glutamine from glutamate and ammonia. That target is relevant in tuberculosis research, where the bacterium’s glutamine synthetase is essential for survival, and the compound showed antimycobacterial activity in lab assays.12Tuberculosis. Quercetin 3-O-glucoside recovered from the wild Egyptian Sahara plant, Euphorbia paralias L., inhibits glutamine synthetase and has antimycobacterial activity Whether dietary quercetin at the amounts found in food would meaningfully inhibit human glutamine synthetase is a separate and unanswered question.
Xanthohumol and Other Polyphenols That Reduce Glutamine Uptake
A screening study tested fifteen different polyphenols for their ability to reduce glutamine uptake in breast cancer cells. Several of them showed some effect, but xanthohumol, a compound from hops, stood out. It markedly decreased both total and sodium-dependent glutamine uptake, acting as an uncompetitive inhibitor of the ASCT2 transporter. It also showed direct cytotoxic and anti-proliferative effects against triple-negative breast cancer cells, one of the harder-to-treat subtypes.13PubMed. Inhibition of Glutamine Cellular Uptake Contributes to the Cytotoxic Effect of Xanthohumol in Triple-Negative Breast Cancer Cells
Xanthohumol is present in beer in very small quantities and available in supplement form, though the concentrations used in the cell study are far higher than what you would get from dietary sources. The broader finding from that same screening is worth noting: multiple polyphenols including catechin, naringenin, kaempferol, and myricetin all interfered with glutamine uptake to varying degrees. This suggests that a polyphenol-rich diet may create a low-level cumulative drag on glutamine transport, though “low-level” is the operative term.
A separate line of research identified yuanhuacine, a compound from the Daphne genkwa plant used in traditional Chinese medicine, as a potent promoter of ASCT2 degradation. Rather than simply blocking the transporter, yuanhuacine triggers the cell to destroy it, leading to dose-dependent inhibition of glutamine uptake and mitochondrial dysfunction in head and neck cancer cells.14PubMed Central. Yuanhuacine suppresses head and neck cancer growth by promoting ASCT2 degradation and inhibiting glutamine uptake Daphne genkwa is toxic in crude form, so this is more relevant to drug development than to dietary strategies.
The Ketogenic Diet Angle
One of the more provocative ideas in this space is combining a calorie-restricted ketogenic diet with glutamine-targeting compounds. The logic is that a very low-carbohydrate diet starves cancer cells of glucose, their primary fuel, while simultaneously attacking their backup fuel source, glutamine. In an experimental glioblastoma mouse model, the combination of a calorie-restricted ketogenic diet with a glutamine-targeting drug reduced tumor burden by about 75% more than either approach alone, suggesting genuine synergy rather than simply adding two small effects together.15PubMed Central. Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma
A clinical research framework has since been proposed for testing this “ketogenic metabolic therapy” approach in human glioblastoma patients, describing it as a strategy that simultaneously inhibits both glycolysis and glutaminolysis while shifting the body’s energy metabolism toward therapeutic ketosis.16PubMed Central. Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma The drug used in the mouse study was DON (6-diazo-5-oxo-L-norleucine), not a natural compound, but the dietary half of the equation, calorie restriction on a ketogenic diet, is something a person can implement. Whether combining it with the natural compounds described above would mimic the synergy seen with pharmaceutical glutamine inhibitors is completely speculative at this point.
AMPK Activation as an Indirect Route
Some natural compounds affect glutamine metabolism indirectly by activating AMPK, a cellular energy sensor that acts as a master switch for metabolic pathways. Research has shown that reactivating AMPK blocks glutamine-dependent activation of the growth-signaling pathway mTORC1 and prevents a form of cell death called glutamoptosis. In these experiments, the diabetes drug metformin was one of the AMPK activators that accomplished this.17Nature Communications. Two parallel pathways connect glutamine metabolism and mTORC1 activity to regulate glutamoptosis While metformin itself is a pharmaceutical, many natural compounds are also known AMPK activators, including berberine and resveratrol, which are already on this list for their direct effects on glutamine transport.
Separately, inhibition of GLS2 (the liver-type glutaminase, which sometimes acts as a tumor suppressor but in other contexts supports cancer growth) has been shown to reduce cancer cell proliferation and trigger autophagy through AMPK-mediated mTORC1 inhibition.18PubMed Central. Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells The compounds used in that study were alkyl benzoquinones, not common dietary ingredients, but the finding illustrates how the AMPK-mTORC1 axis connects glutamine metabolism to cell growth decisions.
Why You Cannot Safely Starve Your Body of Glutamine
Before anyone considers aggressively trying to block glutamine, the safety picture needs to be clear. Glutamine is not just cancer fuel. Your immune system runs on it. Lymphocytes, the white blood cells that fight infections, depend on glutamine for proliferation. Depriving them of it reduces their ability to multiply, alters the signaling molecules they produce, and can trigger immune cell death.19The Journal of Nutrition. Nonnutritive Effects of Glutamine Your gut lining also uses glutamine as a primary fuel, which is why glutamine supplements are sometimes recommended for gut health, the exact opposite of blocking it.
The compounds described in this article mostly work at specific bottlenecks in glutamine processing, not by eliminating glutamine from the body entirely. That distinction matters. Inhibiting GDH or reducing ASCT2 expression in tumor tissue is a far cry from depleting circulating glutamine, which would likely cause immune suppression and gut problems before it affected a tumor. The therapeutic window, the gap between a dose that hurts cancer cells and a dose that hurts healthy tissue, is exactly what researchers are trying to define, and diet alone is a blunt instrument for that purpose.
Glutamine, Your Gut Bacteria, and Circadian Rhythms
Glutamine also plays roles that have nothing to do with cancer and that add complexity to the idea of blocking it. In the gut, glutamine dynamically modulates how intestinal bacteria metabolize amino acids. Adding glutamine to bacterial cultures changes the way they process the arginine, serine, and aspartate families of amino acids and actually reduces bacterial breakdown of most amino acids, including essential ones.20PubMed. L-Glutamine regulates amino acid utilization by intestinal bacteria In other words, glutamine helps preserve amino acids for your own use rather than letting bacteria consume them first. Broadly suppressing glutamine could have unintended effects on nutrient availability and microbial balance.
There is also a circadian dimension. Recent research found that intestinal cells absorb glutamine in a rhythmic pattern governed by the body’s internal clock. During the active phase (daytime for humans), a clock-controlled transporter ramps up glutamine absorption, which in turn activates certain neurons in the brain that promote wakefulness. Mice with disrupted intestinal clocks that produced too much glutamine during the rest phase showed measurable sleep abnormalities.21Cell Press (Cell Metabolism). Intestinal clock shapes sleep-wake cycle via sustaining glutamine homeostasis This suggests that glutamine homeostasis is tied to sleep regulation, and interfering with it carelessly could affect sleep quality.
How Exercise Temporarily Shifts Glutamine Levels
Intense exercise is one of the few non-dietary interventions that measurably alters glutamine metabolism. In rats, a single bout of exercise dropped plasma glutamine while simultaneously increasing the activity of glutamine synthetase in skeletal muscle, as if the muscle was trying to replenish what was being consumed. Twenty-four hours later, plasma glutamine had returned to baseline, but glutamine, glutamate, and ammonia levels within the muscle itself were all lower than in sedentary animals.22PubMed Central. Effect of exercise on glutamine synthesis and transport in skeletal muscle from rats The temporary post-exercise dip in circulating glutamine is well-documented and is one reason heavy training can temporarily suppress immune function.
For someone interested in reducing glutamine availability to a tumor, exercise creates a short-lived window of lower plasma glutamine, but there is no evidence that this window is long enough or deep enough to have any anti-cancer effect. The body rapidly compensates. What exercise does offer is metabolic flexibility and improved insulin sensitivity, which could complement dietary strategies like calorie restriction or ketogenic eating by making the body better at using alternative fuels while limiting the glucose that tumors also crave.
Practical Takeaways for a Polyphenol-Rich Approach
If you are looking at this topic because of a cancer diagnosis or cancer prevention interest, the most reasonable dietary strategy based on current evidence is not to try to “block glutamine” per se but to regularly consume foods rich in the compounds that have shown activity against glutamine metabolism pathways. Green tea for EGCG, broccoli sprouts for sulforaphane, red grapes and berries for resveratrol, onions and apples for quercetin, and turmeric-containing foods for curcumin (which was not in these studies but activates AMPK through related mechanisms) collectively represent a polyphenol-dense dietary pattern that hits multiple nodes of glutamine processing simultaneously.
The realistic expectation should be modest. These foods will not replicate the potency of pharmaceutical glutaminase inhibitors like CB-839, which are being tested in actual clinical trials. Pharmaceutical approaches can combine a glutaminase inhibitor with a transporter blocker to deplete glutathione and trigger cancer cell death through oxidative stress, an effect that dietary polyphenols at food-level doses are unlikely to achieve. But dietary compounds have the advantage of safety at normal consumption levels, potential additive effects from consuming multiple types, and the ability to be maintained over years rather than weeks of a drug trial. Think of them as a background influence on metabolic terrain rather than a targeted weapon.